It has been demonstrated that XIST knockdown exhibited tumor-suppressive impacts on glioblastoma CSCs by lowering cell proliferation, migration, and invasion as well as triggering apoptosis via up-regulation of miR-152. The gene discussed is XIST; the disease is glioblastoma.